Journal Name: Journal of Cancer Research and Oncobiology
ISSN: 2517-7370
DOI: 10.31021
Indexing: Click Here
Journal Type: Open Access
Contact Us: Click Here
The Journal of Cancer Research and Oncobiology (JCRO) is an international, peer-reviewed, open access journal published by Boffin Access Limited. Dedicated to advancing knowledge in cancer biology and clinical oncology, the journal serves as a trusted platform for researchers, oncologists, clinicians, and healthcare professionals to publish high-quality research that addresses the mechanisms, diagnosis, treatment, and prevention of cancer.
JCRO aims to integrate basic, translational, and clinical research to accelerate the discovery of novel therapies and improve patient outcomes across diverse cancer types.
The Journal of Cancer Research and Oncobiology welcomes contributions in all areas of oncology and cancer biology, including but not limited to:
Molecular and cellular mechanisms of tumor initiation and progression
Cancer genetics, epigenetics, and genomics
Tumor immunology, immunotherapy, and checkpoint inhibitors
Precision medicine, targeted therapies, and personalized oncology
Radiotherapy, chemotherapy, and combination treatment approaches
Cancer biomarkers for diagnosis, prognosis, and therapeutic monitoring
Experimental oncology and preclinical cancer models
Oncogenic signaling pathways and tumor microenvironment studies
Epidemiology, prevention, and early cancer detection strategies
Clinical trials, case studies, and novel therapeutic interventions
Palliative care, survivorship, and quality-of-life research in oncology
Global Visibility – Open access ensures your research is freely available to scientists, clinicians, and policymakers worldwide.
Rigorous Peer Review – Submissions undergo double-blind peer review to ensure scientific quality and originality.
Rapid Publication – Fast-track editorial processing allows timely dissemination of impactful cancer research.
Expert Editorial Board – Managed by distinguished oncologists, cancer biologists, and clinical researchers.
Multidisciplinary Scope – Bridges laboratory discoveries with clinical oncology, fostering translational impact.
Author Rights – Authors retain copyright under Creative Commons licensing, supporting wide reuse and citation.
High Impact Potential – Articles benefit from digital promotion, indexing, and distribution across academic networks.
The Journal of Cancer Research and Oncobiology adheres to the ethical publishing principles outlined by COPE and ICMJE. Manuscripts are evaluated based on scientific merit, with complete transparency, fairness, and confidentiality maintained throughout the editorial process.
SCINEXI is committed to upholding the integrity and credibility of the scholarly record. In accordance with international publishing ethics, articles may be retracted when found to contain serious errors, evidence of research misconduct, copyright infringement, or plagiarism. Retraction is a necessary step to safeguard academic reliability and to ensure that the literature remains a trustworthy resource for the global research community.
If you wish to report a concern regarding any published article, please share the details with us by clicking below:
Send Information
Stay connected with SCINEXI. Enter your e-mail address to receive alerts on newly published articles, special issue announcements, and the latest updates from our journals.
At SCINEXI, we actively welcome feedback and constructive criticism. Your compliments, concerns, and suggestions help us refine our services and elevate the author and reader experience.
Have an idea that could advance the Open Access community? We’d love to hear it. Please write to: support@scinexi.com
Copyright © 2025 BOFFIN ACCESS.